Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes

医学 胎儿 促炎细胞因子 妊娠期 胎龄 炎症 药效学 白细胞介素1受体拮抗剂 怀孕 药理学 敌手 受体 受体拮抗剂 内科学 药代动力学 生物 遗传学
作者
Tiffany Habelrih,David-Étienne Tremblay,Erica Di Battista,Xin Hou,Allan Reuben,Béatrice Ferri,Sarah-Ève Loiselle,France Côté,Pénélope Abram,William D. Lubell,Kelycia B Leimert,Christiane Quiniou,Sylvie Girard,David M. Olson,Sylvain Chemtob
出处
期刊:American Journal of Obstetrics and Gynecology [Elsevier BV]
卷期号:228 (4): 467.e1-467.e16 被引量:8
标识
DOI:10.1016/j.ajog.2022.10.007
摘要

Abstract:

Background

Preterm birth is the leading cause of neonatal morbidity and mortality. Studies have shown that interleukin-1 plays a major role in the pathophysiology of preterm birth participating by inducing the production of pro-inflammatory mediators and uterine activating proteins leading to labor. More importantly, uteroplacental inflammation, associated with preterm birth parturition pathways, is detrimental to fetal tissues and leads to long term sequelae. Our group has developed an allosteric antagonist of the interleukin-1 receptor, rytvela, found to be potent and safe in preventing preterm birth by suppressing inflammation via the inhibition of the MAP-Kinase pathway while preserving the NF-kB pathway (important in immune vigilance). Rytvela has been shown to inhibit inflammatory upregulation and uterine activation while preserving fetal development.

Objectives

The study aimed to further pre-clinical development of rytvela by evaluating its optimal dose and minimal duration of treatment to inhibit the inflammatory cascade, prolong gestation and promote neonatal outcome.

Study design

Pregnant CD-1 mice were injected with LPS (10 ug i.p.) or interleukin-1 (1 ug/kg i.u.) on gestational day 16 to induce preterm labor. Rytvela was injected at different doses (0.1, 0.5, 1, 2, 4 mg/kg/day s.c.) from gestational day 16 to 19. To evaluate the minimal duration of treatment, mice were injected with Rytvela (2 mg/kg/day s.c.) over the course of 24, 36 or 48 hours. Rate of prematurity (gestational day<18.5) and neonate survival and weight were evaluated. Gestational tissues were collected at gestational day 17.5 to quantify cytokines, pro-inflammatory mediators, and uterine activating proteins by RT-qPCR and ELISA. Neonatal lungs and intestines were collected from postnatal day 5 to 7 and analyzed by histology.

Results

Rytvela exhibited a dose-response profile and achieved EMAX at a dose of 2 mg/kg/day by reducing 70% of LPS-induced preterm births as well as 60% of IL-1β-induced preterm births. Rytvela also attained EMAX at a dose of 1 mg/kg/day by increasing neonate survival by up to 65% in both models of preterm birth. Rytvela protects fetuses from inflammatory insult as of 24 hours preserving lung and intestinal integrity and prevents preterm birth and fetal mortality by 60% and 50% respectively as of 36 hours of treatment.

Conclusions

The EMAX of Rytvela was achieved at 2 mg/kg/day with improved birth outcome and prevented inflammatory upregulation upon (only) 36 hours of treatment. Rytvela exhibits desirable properties for the safe prevention of preterm birth and fetal protection.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
上官若男的应助被科研通管家采纳,获得10
刚刚
无极微光的应助被科研通管家采纳,获得20
刚刚
李健的小迷弟的应助被lbh采纳,获得10
刚刚
万能图书馆的应助被入司采纳,获得10
1秒前
个性天晴完成签到 ,获得积分10
1秒前
Atom发布了新的文献求助10
1秒前
Nole的应助被火山采纳,获得30
2秒前
深情海秋完成签到,获得积分10
3秒前
所所的应助被繁星jia采纳,获得10
3秒前
3秒前
4秒前
fufu完成签到,获得积分10
5秒前
隐形曼青的应助被帅子采纳,获得10
5秒前
5秒前
Linjm完成签到 ,获得积分10
5秒前
7秒前
8秒前
8秒前
year完成签到 ,获得积分10
9秒前
震甫完成签到,获得积分10
9秒前
喔吼完成签到,获得积分10
9秒前
俊逸的映易完成签到,获得积分10
9秒前
9秒前
111发布了新的文献求助10
9秒前
10秒前
11秒前
11秒前
11秒前
Nole的应助被大方的笑萍采纳,获得10
12秒前
Smile_Uo完成签到,获得积分10
12秒前
12秒前
咻咻发布了新的文献求助10
13秒前
知行合一完成签到,获得积分10
13秒前
小马发布了新的文献求助10
15秒前
lbh发布了新的文献求助10
15秒前
obtu发布了新的文献求助10
15秒前
yzw发布了新的文献求助10
16秒前
Elaine完成签到,获得积分10
16秒前
木木完成签到 ,获得积分10
16秒前
汉堡包的应助被自由的若之采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192250
求助须知:如何正确求助?哪些是违规求助? 9578881
关于积分的说明 21862513
捐赠科研通 7791814
什么是DOI,文献DOI怎么找? 3436868
关于科研通互助平台的介绍 2560584
邀请新用户注册赠送积分活动 2483698